Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/2196 stock hub

HKG/2196 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2196is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

70.3B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2196

In the news

Latest news · HKG/2196

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E17.8

P25 10.7P50 17.9P75 38.5

ROE7

P25 -14.7P50 2P75 9.4

ROIC3

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2196 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

CNY

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	40,603
Employees Change	-323%
Employees Change Percent	-0.8
Enterprise value	HKD 114.9B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100001M79
Last refreshed	2026-05-10
Market cap	HKD 70.3B
Price	HKD 19.07
Price currency	HKD
Rev Per Employee	1,184,580.69x
Sector	Healthcare
Sic	2834
Symbol	hkg/2196
Website	https://www.fosunpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.62%
EV Earnings	29.08x
EV/EBIT	33.76x
EV/EBITDA	15.25x
EV/FCF	114.23x
EV/Sales	2.36x
FCF yield	1.43%
P/B ratio	0.97x
P/E ratio	17.78x
P/S ratio	1.46x
PE Ratio10 Y	24.88x
PE Ratio3 Y	22.9x
PE Ratio5 Y	24.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.99%
EBITDA Margin	14.6%
FCF margin	2.09%
Gross margin	50.31%
Gross Profit	HKD 24.2B
Gross Profit Growth	11.69%
Gross Profit Growth Q	11.25%
Gross Profit Growth3 Y	-0.71%
Gross Profit Growth5 Y	4.07%
Net Income	HKD 4B
Net Income Growth	18.86%
Net Income Growth Q	13.87%
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Net Income Growth3 Y	-6.56%
Net Income Growth5 Y	-2.44%
Pretax Margin	12.1%
Profit Margin	8.22%
Profit Per Employee	HKD 97,327
Profitable Years	31
ROA	1.53
Roa5y	1.53
ROCE	3.42
ROE	7.04
Roe5y	7.3
ROIC	2.96
Roic5y	3.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.09%
Cagr1y	39.11%
Cagr3y	-3.51%
Cagr5y	-15.98%
Div CAGR10	-0.77%
Div CAGR3	-8.71%
Div CAGR5	-7.61%
EPS Growth	19.43
EPS Growth Q	13.79
EPS Growth Quarters	2
EPS Growth Years	2
EPS Growth3 Y	-6.71
EPS Growth5 Y	-3.01
FCF Growth	159.5%
OCF Growth	14.97%
OCF Growth Q	8.8%
OCF Growth10 Y	11.28%
OCF Growth3 Y	7.8%
OCF Growth5 Y	12.58%
Revenue Growth	4.92x
Revenue Growth Q	6.93x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.62x
Revenue Growth5 Y	5.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.35
Assets	HKD 139.8B
Cash	HKD 17.4B
Current Assets	HKD 39.1B
Current Liabilities	HKD 42.1B
Debt	HKD 44.9B
Debt EBITDA	HKD 6.04
Debt Equity	HKD 0.62
Debt FCF	HKD 44.67
Equity	HKD 72.4B
Interest Coverage	2.4
Liabilities	HKD 67.4B
Long Term Assets	HKD 100.7B
Long Term Liabilities	HKD 25.3B
Net Cash	HKD -27.6B
Net Cash By Market Cap	HKD -39.2
Net Debt EBITDA	HKD 3.92
Net Debt Equity	HKD 0.38
Net Debt FCF	HKD 27.39
Tangible Book Value	HKD 27.6B
Tangible Book Value Per Share	HKD 10.44
WACC	5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.93
Inventory Turnover	3.27
Net Working Capital	HKD 7B
Quick ratio	0.71
Working Capital	HKD -3B
Working Capital Turnover	HKD -26.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.76%
Dividend Growth	16.67%
Dividend Growth Years	1%
Dividend per share	HKD 0.35
Dividend Years	13
Dividend Yield	1.85%
Ex Div Date	2025-07-24
Last Dividend	HKD 0.35
Payout Frequency	Annual
Payout Ratio	62.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	11.43%
1Y total return	39.08%
200-day SMA	21.41
3Y total return	-10.17%
50-day SMA	19.56
50-day SMA vs 200-day SMA	50under200
5Y total return	-58.12%
All Time High	82
All Time High Change	-76.74%
All Time High Date	2021-08-05
All Time Low	10.38
All Time Low Change	83.72%
All Time Low Date	2012-10-30
ATR	0.6
Beta	0.41
Ch YTD	-2.46
High	19.24
High52	29
High52 Date	2025-09-16
High52ch	-34.24%
Low	18.8
Low52	13.72
Low52 Date	2025-05-12
Low52ch	38.99%
Ma50ch	-2.49%
Price vs 200-day SMA	-10.93%
RSI	42.43
RSI Monthly	49.97
RSI Weekly	42.38
Sharpe ratio	0.83x
Sortino ratio	1.55
Total Return	2.61%
Tr YTD	-2.46
Tr1m	-8.32%
Tr1w	-0.31%
Tr3m	-6.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 3.4B
Operating Income Growth	11.95
Operating Income Growth Q	25.74
Operating Income Growth3 Y	-6.87
Operating Income Growth5 Y	0.51
Operating margin	6.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,635,575,347%
Net Borrowing	988,449,662.3
Shares Insiders	0.59%
Shares Institutions	15.85%
Shares Qo Q	0.84%
Shares Yo Y	-0.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 770.3M
Average Volume	2,451,474.35x
Bv Per Share	21.16
CAPEX	HKD -5B
Ch10y	-5.83
Ch1m	-8.32
Ch1w	-0.31
Ch1y	36.41
Ch3m	-6.52
Ch3y	-15.81
Ch5y	-61.9
Ch6m	-14.94
Change	-0.16%
Change From Open	0.63
Close	19.1
Days Gap	-0.79
Depreciation Amortization	3,709,304,689.7
Dollar Volume	67,294,654.6
Earnings Date	2026-04-28
EBIT	HKD 3.4B
EBITDA	HKD 7B
EPS	HKD 1.49
F Score	6
FCF	HKD 1B
FCF EV Yield	0.88x
Financing CF	-1,514,344,540
Fiscal Year End	December
Founded	1,994
Goodwill	12,433,156,913.1
Graham Number	21.76728
Graham Upside	14.14
Income Tax	HKD 836.6M
Investing CF	-4,194,256,712
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Lynch Fair Value	HKD 5.36
Lynch Upside	-71.88
Ma150	21.23
Ma150ch	-10.17%
Ma20	19.73
Ma20ch	-3.34%
Net CF	-68,626,598
Next Earnings Date	2026-08-26
Open	18.95
P FCF Ratio	69.87
P OCF Ratio	11.65
Payment Date	2025-08-22
Position In Range	61.36
Ppne	27,971,963,960.5
Price Date	2026-05-08
Price EBITDA	HKD 10.01
Ptbv Ratio	2.55
Relative Volume	1.47x
Revenue	48,097,529,652x
SBC By Revenue	0.49x
Share Based Comp	235,568,615
Tax By Revenue	1.74x
Tax Rate	14.37%
Tr6m	-14.94%
Volume	3,528,823
Z Score	1.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/2196 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$0.35 annual per share

Payout ratio

+62.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.6%

1 consecutive years of growth

Total shareholder yield

+2.6%

Next ex-dividend date: 2025-07-24

Performance

HKG/2196 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2196?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.9%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

HKG/2196 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.4

Neutral momentum band

Price vs 200-day MA

-10.9%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2196

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2196 stock rating?

hkg/2196 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2196 analysis?

The full report lives at /stocks/hkg/2196/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2196?

The latest report frames hkg/2196 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2196 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.